[ Price : $8.95]
FDA grants Conatus Pharmaceuticals an orphan drug designation for emricasan and its use in treating liver transplant recipients wh...[ Price : $8.95]
FDA grants 510(k) clearance to Sumitomo Heavy Industries for its Proton Therapy System to kill cancer cells.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget in a guidance on ...[ Price : $8.95]
FDA researchers say acellular pertussis vaccines are effective in preventing disease but not as effective in preventing infection ...[ Price : $8.95]
A McKinsey analysis finds that FDA follows recommendations of advisory committees to approve or not approve an NDA or BLA nearly 9...[ Price : $8.95]
FDA accepts for priority review a Durata Therapeutics NDA for Dalvance (dalbavancin hydrochloride) for injection for treating pati...[ Price : $8.95]
FDA grants VBL Therapeutics a fast track designation for its lead oncology drug VB-111 and its use in prolonging survival in patie...[ Price : $8.95]
Former FDA Office of Regulatory Affairs manager William Schwemer asks FDA to issue new rules governing marketing of homeopathic dr...